Maruti Suzuki: Anand Tandon, CEO, JRG Securities recommends buy rating Maruti Suzuki on decline.
Tandon told CNBC-TV18, "Maruti Suzuki is perhaps a little worrying sign not because of what happened in it, but more because what it signals on the working segment in the country overall. I think the fact that inflation is booming is what is perhaps playing on the fact that you have a situation where you need to drive more efficiency in manufacturing units and perhaps reduce cost, at the same time salaries need to be increased upwards and that's going to affect a lot of corporate India."
Dr Reddys Laboratories: Two analysts have put a buy option. First call research has put a buy on Dr Reddy's Lab with target of Rs 1,824 in its July 20, 2012 research report.
"We expect that the company surplus scenario is likely to continue for the next three years, will keep its growth story in the coming quarters also. We recommend ‘BUY' in this particular scrip with a target price of Rs 1824 for medium to long term investment," says Firstcall Research report.
Motilal Oswal has recommended the stock with target of Rs 1,990.
Karur Vysya Bank: Dolat Capital is bullish on Karur Vysya Bank and has recommended buy rating on the stock with a target of Rs 512 in its July 20, 2012 research report.
Dish TV: Emkay Global Financial Services is bullish on Dish TV India and has recommended buy rating on the stock with a target of Rs 79 in its July 19, 2012 research report.
DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article